Table 1.
Characteristics of all patients, and those with Tn leaks, EF < 55% and wall motion abnormalities.a
| Overall | Tn leak | EF < 55% | Any WMA | |
|---|---|---|---|---|
| Patients | 286 | 107/286 (37%) | 31/169 (18%) | 25/169 (15%) |
| Age (Mean +/− SD) | 54.9 (14.2) | 58.9 (14.3) | 60.4 (15.8) | 58.8 (15.5) |
| Female Gender | 216/286 (76%) | 83/107 (78%) | 26/31 (84%) | 20/25 (80%) |
| Medical History: | ||||
| Hypertension | 135/286 (47%) | 48/107 (45%) | 8/31 (26%) | 6/25 (24%) |
| Hyperlipidemia | 56/286 (20%) | 19/107 (18%) | 4/31 (13%) | 2/25 (8%) |
| Diabetes | 18/286 (6%) | 7/107 (7%) | 2/31 (6%) | 1/25 (4%) |
| CAD | 20/286 (7%) | 10/107 (9%) | 4/31 (13%) | 3/25 (12%) |
| Medications: | ||||
| Statin | 32/286 (11%) | 12/107 (11%) | 5/31 (16%) | 3/25 (12%) |
| Beta Blocker | 39/286 (14%) | 16/107 (15%) | 6/31 (19%) | 4/25 (16%) |
| ACE-Inhibitor | 28/286 (10%) | 10/107 (9%) | 1/31 (3%) | 1/25 (4%) |
| Aspirin | 38/286 (13%) | 14/107 (13%) | 2/31 (6%) | 1/25 (4%) |
| Current Smoker | 112/286 (39%) | 44/107 (41%) | 12/31 (39%) | 10/25 (40%) |
| Hunt-Hess 4–5 | 77/286 (27%) | 56/107 (52%) | 20/31 (65%) | 18/25 (72%) |
| Thick SAH (Fisher 3) | 193/286 (67%) | 91/107 (85%) | 28/31 (90%) | 23/25 (92%) |
| EKG Changes: | ||||
| QT Prolonged | 36/286 (13%) | 22/107 (21%) | 5/31 (16%) | 3/25 (12%) |
| T-wave changes | 45/286 (16%) | 40/107 (37%) | 13/31 (42%) | 12/25 (48%) |
a
Tn, troponin; EF, ejection fraction; WMA, wall motion abnormality; SD, standard deviation; CAD, coronary artery disease; SAH, subarachnoid hemorrhage; ICA, internal carotid artery; ACA, anterior cerebral artery; MCA, middle cerebral artery.